Implantable Defibrillator System Shock Function, Mortality, and Cause of Death After Magnetic Resonance Imaging

被引:0
|
作者
Ra, Joshua [1 ,6 ]
Oberdier, Matt T. T. [2 ]
Suzuki, Masahito [2 ]
Vaidya, Dhananjay [2 ]
Liu, Yisi [3 ]
Hansford, Rozann [2 ]
McVeigh, Diana [2 ]
Weltin, Valeria [2 ]
Tao, Susumu [2 ]
Thiemann, David R. [2 ]
Nazarian, Saman [4 ]
Halperin, Henry R. [5 ]
机构
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[2] Johns Hopkins Univ, Dept Cardiol, Baltimore, MD USA
[3] Johns Hopkins Univ, Dept Pediat, Baltimore, MD USA
[4] Univ Penn Perelman, Sch Med, Dept Cardiol, Philadelphia, PA USA
[5] Johns Hopkins Univ, Dept Cardiol, Dept Radiol & Biomed Engn, Baltimore, MD USA
[6] Univ Calif San Francisco, Dept Med, 521 Parnassus Ave, San Francisco, CA 94143 USA
基金
美国国家卫生研究院;
关键词
INDUSTRY VIEWPOINT; SAFE PERFORMANCE; CARDIOVERTER-DEFIBRILLATORS; CLINICAL SAFETY; ABSORPTION RATE; PACEMAKERS; MRI; ICDS; PROTOCOL; DEVICES;
D O I
10.7326/M22-2653
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Studies have shown that magnetic resonance imaging (MRI) does not have clinically important effects on the device parameters of non-MRI-conditional implantable cardioverter-defibrillators (ICDs). However, data on non-MRI-conditional ICD detection and treatment of arrhythmias after MRI are limited.Objective: To examine if non-MRI-conditional ICDs have preserved shock function of arrhythmias after MRI.Design: Prospective cohort study. (ClinicalTrials.gov: NCT01130896)Setting: 1 center in the United States.Patients: 629 patients with non-MRI-conditional ICDs enrolled consecutively between February 2003 and January 2015.Interventions: 813 total MRI examinations at a magnetic field strength of 1.5 Tesla using a prespecified safety protocol.Measurements: Implantable cardioverter-defibrillator inter-rogations were collected after MRI. Clinical outcomes included arrhythmia detection and treatment, generator or lead exchanges, adverse events, and death.Results: During a median follow-up of 2.2 years from MRI to latest available ICD interrogation before generator or lead exchange in 536 patients, 4177 arrhythmia episodes were detected, and 97 patients received ICD shocks. Sixty-one patients (10% of total) had 130 spontaneous ventricular tachycardia or fibrillation events terminated by ICD shocks. A total of 210 patients (33% of total) are known to have died (median, 1.7 years from MRI to death); 3 had cardiac arrhythmia deaths where shocks were indicated without direct evidence of device dysfunction.Limitations: Data were acquired at a single center and may not be generalizable to other clinical settings and MRI facilities. Implantable cardioverter-defibrillator interrogations were not avail-able for a subset of patients; adjudication of cause of death relied solely on death certificate data in a subset.Conclusion: Non-MRI-conditional ICDs appropriately treated detected tachyarrhythmias after MRI. No serious adverse effects on device function were reported after MRI.
引用
收藏
页码:289 / 297
页数:10
相关论文
共 50 条
  • [31] Correlation between vectorcardiographic measures and cardiac magnetic resonance imaging of the left ventricle in an implantable cardioverter defibrillator population
    Shi, Bijia
    Ferrier, Katherine A.
    Sasse, Alexander
    Harding, Scott A.
    Larsen, Peter D.
    JOURNAL OF ELECTROCARDIOLOGY, 2014, 47 (01) : 52 - 58
  • [32] Committed function for the first delivered shock of an uncommitted implantable cardioverter-defibrillator
    Stroobandt, Roland X.
    Barold, S. Serge
    CARDIOLOGY JOURNAL, 2011, 18 (05) : 570 - 572
  • [33] Clinical Safety of an MRI Conditional Implantable Cardioverter Defibrillator System: A Prospective Monocenter ICD-Magnetic Resonance Imaging Feasibility Study (MIMI)
    Kypta, Alexander
    Blessberger, Hermann
    Hoenig, Simon
    Saleh, Karim
    Lambert, Thomas
    Kammler, Juergen
    Fellner, Franz
    Lichtenauer, Michael
    Steinwender, Clemens
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2016, 43 (03) : 574 - 584
  • [34] Implantable cardioverter-defibrillator shock prevention does not reduce mortality: A systemic review
    Ha, Andrew H.
    Ham, Inje
    Nair, Girish M.
    Connolly, Stuart J.
    Dorian, Paul
    Morillo, Carlos A.
    Healey, Jeff S.
    HEART RHYTHM, 2012, 9 (12) : 2068 - 2074
  • [35] Relation between total shock energy and mortality in patients with implantable cardioverter-defibrillator
    Tenma, Taro
    Yokoshiki, Hisashi
    Mitsuyama, Hirofumi
    Watanabe, Masaya
    Mizukami, Kazuya
    Kamada, Rui
    Takahashi, Masayuki
    Sasaki, Ryo
    Maeno, Motoki
    Okamoto, Kaori
    Chiba, Yuki
    Anzai, Toshihisa
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 259 : 94 - 99
  • [36] The role of cardiovascular magnetic resonance in appropriate selection of implantable cardioverter defibrillator therapy
    James, S. Stephanie
    Waterhouse, D.
    Mc Adam, B.
    Foley, D.
    Sheahan, R.
    O' Hanlon, R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 326 - 327
  • [37] Diagnostic and Prognostic Role of Cardiac Magnetic Resonance Before Implantable Cardioverter Defibrillator
    Lilli, Alessio
    Tessa, Carlo
    Del Meglio, Jacopo
    Salvatori, Luca
    Comella, Alessandro
    Magnacca, Massimo
    Poddighe, Rosa
    Canale, Maria Laura
    Solarino, Gianluca
    Baratto, Marco T.
    Vignali, Claudio
    Casolo, Giancarlo
    AMERICAN JOURNAL OF CARDIOLOGY, 2019, 123 (05): : 801 - 806
  • [38] Implantable Cardioverter-Defibrillator Shock after Stenting Across the Device Leads
    Mehra, Sanjay
    Chelu, Mihail Gabriel
    TEXAS HEART INSTITUTE JOURNAL, 2016, 43 (01): : 88 - 90
  • [39] Predictors of appropriate shock after generator replacement in patients with an implantable cardioverter defibrillator
    Arcinas, Liane A.
    Chew, Derek S.
    Seifer, Colette M.
    Baranchuk, Adrian
    Supel, Izabella
    Exner, Derek V.
    Boles, Usama
    McIntyre, William F.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2021, 44 (05): : 911 - 918
  • [40] SCAR HETEROGENEITY ON CARDIAC MAGNETIC RESONANCE IMAGING IS A PREDICTOR OF APPROPRIATE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR THERAPY: 10 YEARS OF EXPERIENCE
    Rayatzadeh, Hussein
    Tan, Alex
    Hauser, Thomas
    Shaw, Jaime
    Patel, Shalin
    Hong, Susie
    Chan, Raymond
    Zimetbaum, Peter
    Buxton, Alfred
    Josephson, Mark
    Manning, Warren
    Nezafat, Reza
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E1081 - E1081